Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.770
+0.010 (0.57%)
At close: Sep 17, 2025, 4:00 PM EDT
1.780
+0.010 (0.56%)
After-hours: Sep 17, 2025, 7:53 PM EDT
Organigram Global Market Cap
Organigram Global has a market cap or net worth of $238.24 million as of September 17, 2025. Its market cap has increased by 24.08% in one year.
Market Cap
238.24M
Enterprise Value
264.96M
1-Year Change
24.08%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since May 21, 2019, Organigram Global's market cap has decreased from $1.01B to $238.24M, a decrease of -76.53%. That is a compound annual growth rate of -20.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 237.20M | 35.70% |
| Dec 31, 2024 | 174.80M | 64.44% |
| Dec 29, 2023 | 106.30M | -57.67% |
| Dec 30, 2022 | 251.10M | -51.98% |
| Dec 31, 2021 | 522.90M | 151.76% |
| Dec 31, 2020 | 207.70M | -45.73% |
| Dec 31, 2019 | 382.70M | -62.29% |
| May 21, 2019 | 1.01B | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |